{"abstract":"The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee. This notice is being published less than 15 days prior to the date of the meeting. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.","action":"Notice; establishment of a public docket; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2019/12/04/2019-26222.html","cfr_references":[],"citation":"84 FR 66429","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The meeting will be held on December 17, 2019, from 8 a.m. to 5 p.m.","disposition_notes":null,"docket_ids":["Docket No. FDA-2019-N-5119"],"dockets":[],"document_number":"2019-26222","effective_on":null,"end_page":66430,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2019/12/04/2019-26222.xml","html_url":"https://www.federalregister.gov/documents/2019/12/04/2019-26222/oncologic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2019-26222?publication_date=2019-12-04","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2019-12-04/2019-26222/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":952,"last_updated":"2026-08-25 10:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-12-04/pdf/2019-26222.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-26222.pdf?1575294323","publication_date":"2019-12-04","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2019/12/04/2019-26222.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2019-N-5119","supporting_documents_count":0,"docket_id":"FDA-2019-N-5119","regulation_id_number":null,"title":"Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments","checked_regulationsdotgov_at":"2019-12-18T04:30:09Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":66429,"subtype":null,"title":"Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments","toc_doc":"Oncologic Drugs Advisory Committee","toc_subject":"Meetings:\n","topics":[],"type":"Notice","volume":84}